More than $50 million in private funding has the City of Hope research and treatment center setting the lofty goal today of curing Type 1 diabetes in six years. In 1978, one of City of Hopes researchers, Arthur D. Riggs, developed a synthetic human insulin used today by an estimated 1.5 million Americans with Type 1 diabetes and 27 million with Type 2 diabetes. The city of Hope is best positioned to take on this challenge, said Robert W. Stone, president, and CEO of the City of Hope.
- January 24, 2017
- by :